Laboratory and Genetic Evaluation of Gaucher Disease

Overview

Journal Wien Med Wochenschr

Specialty General Medicine

Date 2010 Aug 18

PMID 20714811

Citations 9

Authors

Olaf A Bodamer

Christina Hung

Affiliations

Soon will be listed here.

Abstract

Gaucher disease (GD) is an inherited lysosomal storage disorder due to deficiency of glucocerebrosidase. Diagnosis of GD may be suspected based on clinical symptoms and confirmed by the analysis of glucocerebrosidase in total white cells, mononuclear cells, fibroblasts and dried blood on filter paper. Low enzyme activities should be followed by molecular analysis of the GBA gene. Although there is no obvious genotype-phenotype correlation, the presence of p.N370S protects from neurological involvement whereas homozygosity of p.L444P mostly leads to a neuronopathic form of GD. Progressive storage of glucosylceramide in mononuclear cells and macrophages results in elevated levels of chitotriosidase and CCL18/PARC which may be used as biomarker to assess disease severity and efficacy of treatment. Chitotriosidase activities cannot be analysed in at least 6% of GD patients due to a null mutation in the corresponding gene.

Citing Articles

Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1.

Dardis A, Michelakakis H, Rozenfeld P, Fumic K, Wagner J, Pavan E Orphanet J Rare Dis. 2022; 17(1):442.

PMID: 36544230 PMC: 9768924. DOI: 10.1186/s13023-022-02573-6.

Bone disease in early detected Gaucher Type I disease: A case report.

Gragnaniello V, Burlina A, Manara R, Cazzorla C, Rubert L, Gueraldi D JIMD Rep. 2022; 63(5):414-419.

PMID: 36101816 PMC: 9458614. DOI: 10.1002/jmd2.12314.

Consequences of excessive glucosylsphingosine in glucocerebrosidase-deficient zebrafish.

Lelieveld L, Gerhardt S, Maas S, Zwiers K, de Wit C, Beijk E J Lipid Res. 2022; 63(5):100199.

PMID: 35315333 PMC: 9058576. DOI: 10.1016/j.jlr.2022.100199.

Twenty- five years of biochemical diagnosis of Gaucher disease: the Egyptian experience.

Fateen E, Abdallah Z Heliyon. 2019; 5(10):e02574.

PMID: 31720445 PMC: 6838951. DOI: 10.1016/j.heliyon.2019.e02574.

Nine-year experience in Gaucher disease diagnosis at the Spanish reference center Fundación Jiménez Díaz.

Ortiz-Cabrera N, Gallego-Merlo J, Velez-Monsalve C, de Nicolas R, Mas S, Ayuso C Mol Genet Metab Rep. 2016; 9:79-85.

PMID: 27872820 PMC: 5109262. DOI: 10.1016/j.ymgmr.2016.06.008.

References

Li Y, Scott C, Chamoles N, Ghavami A, Pinto B, Turecek F . Direct multiplex assay of lysosomal enzymes in dried blood spots for newborn screening. Clin Chem. 2004; 50(10):1785-96. PMC: 3428798. DOI: 10.1373/clinchem.2004.035907. View

Barneveld R, Keijzer W, Tegelaers F, Ginns E, Geurts van Kessel A, Brady R . Assignment of the gene coding for human beta-glucocerebrosidase to the region q21-q31 of chromosome 1 using monoclonal antibodies. Hum Genet. 1983; 64(3):227-31. DOI: 10.1007/BF00279398. View

Sidransky E, Nalls M, Aasly J, Aharon-Peretz J, Annesi G, Barbosa E . Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease. N Engl J Med. 2009; 361(17):1651-61. PMC: 2856322. DOI: 10.1056/NEJMoa0901281. View

Sorge J, West C, Westwood B, Beutler E . Molecular cloning and nucleotide sequence of human glucocerebrosidase cDNA. Proc Natl Acad Sci U S A. 1985; 82(21):7289-93. PMC: 390835. DOI: 10.1073/pnas.82.21.7289. View

Morgan M, Hoffbrand A, LAULICHT M, Luck W, Knowles S . Serum ferritin concentration in Gaucher's disease. Br Med J (Clin Res Ed). 1983; 286(6381):1864. PMC: 1547745. DOI: 10.1136/bmj.286.6381.1864. View

Cox T . Gaucher disease: understanding the molecular pathogenesis of sphingolipidoses. J Inherit Metab Dis. 2002; 24 Suppl 2:106-21; discussion 87-8. DOI: 10.1023/a:1012496514170. View

Goker-Alpan O, Lopez G, Vithayathil J, Davis J, Hallett M, Sidransky E . The spectrum of parkinsonian manifestations associated with glucocerebrosidase mutations. Arch Neurol. 2008; 65(10):1353-7. PMC: 2629407. DOI: 10.1001/archneur.65.10.1353. View

Kate Zhang X, Elbin C, Chuang W, Cooper S, Marashio C, Beauregard C . Multiplex enzyme assay screening of dried blood spots for lysosomal storage disorders by using tandem mass spectrometry. Clin Chem. 2008; 54(10):1725-8. DOI: 10.1373/clinchem.2008.104711. View

Groener J, Poorthuis B, Kuiper S, Hollak C, Aerts J . Plasma glucosylceramide and ceramide in type 1 Gaucher disease patients: correlations with disease severity and response to therapeutic intervention. Biochim Biophys Acta. 2007; 1781(1-2):72-8. DOI: 10.1016/j.bbalip.2007.11.004. View

10.

Choy F . Intrafamilial clinical variability of type 1 Gaucher disease in a French-Canadian family. J Med Genet. 1988; 25(5):322-5. PMC: 1050458. DOI: 10.1136/jmg.25.5.322. View

11.

Boot R, Verhoek M, Langeveld M, Renkema G, Hollak C, Weening J . CCL18: a urinary marker of Gaucher cell burden in Gaucher patients. J Inherit Metab Dis. 2006; 29(4):564-71. DOI: 10.1007/s10545-006-0318-8. View

12.

Hruska K, Lamarca M, Scott C, Sidransky E . Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA). Hum Mutat. 2008; 29(5):567-83. DOI: 10.1002/humu.20676. View

13.

Barak V, Acker M, NISMAN B, Kalickman I, Abrahamov A, Zimran A . Cytokines in Gaucher's disease. Eur Cytokine Netw. 1999; 10(2):205-10. View

14.

Meikle P, Whitfield P, Rozaklis T, Blacklock D, Duplock S, Elstein D . Plasma lipids are altered in Gaucher disease: biochemical markers to evaluate therapeutic intervention. Blood Cells Mol Dis. 2007; 40(3):420-7. DOI: 10.1016/j.bcmd.2007.10.004. View

15.

Jmoudiak M, Futerman A . Gaucher disease: pathological mechanisms and modern management. Br J Haematol. 2005; 129(2):178-88. DOI: 10.1111/j.1365-2141.2004.05351.x. View

16.

Bussink A, Speijer D, Aerts J, Boot R . Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases. Genetics. 2007; 177(2):959-70. PMC: 2034658. DOI: 10.1534/genetics.107.075846. View

17.

Meivar-Levy I, Horowitz M, Futerman A . Analysis of glucocerebrosidase activity using N-(1-[14C]hexanoyl)-D-erythroglucosylsphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease. Biochem J. 1994; 303 ( Pt 2):377-82. PMC: 1137338. DOI: 10.1042/bj3030377. View

18.

Boot R, Renkema G, Verhoek M, Strijland A, Bliek J, de Meulemeester T . The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem. 1998; 273(40):25680-5. DOI: 10.1074/jbc.273.40.25680. View

19.

Sa Miranda M, Aerts J, Pinto R, Fontes A, de Lacerda L, Van Weely S . Activity of glucocerebrosidase in extracts of different cell types from type 1 Gaucher disease patients. Clin Genet. 1990; 38(3):218-27. DOI: 10.1111/j.1399-0004.1990.tb03573.x. View

20.

Staretz-Chacham O, Lang T, Lamarca M, Krasnewich D, Sidransky E . Lysosomal storage disorders in the newborn. Pediatrics. 2009; 123(4):1191-207. PMC: 2768319. DOI: 10.1542/peds.2008-0635. View